[Aminoglycoside toxicity. Pathomechanisms, clinical management and means of prevention].
Lautermann
J
J
Universitäts-Hals-, Nasen-,Ohrenklinik, Essen. ohn020@uni-essen.de
Schacht
J
J
Jahnke
K
K
D017088:AIDS-Related Opportunistic Infections / Q000097:blood / Q000188:drug therapy*; D000617:Aminoglycosides; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000493:pharmacokinetics; D004305:Dose-Response Relationship, Drug; D016903:Drug Monitoring; D016905:Gram-Negative Bacterial Infections / Q000097:blood / Q000188:drug therapy*; D034381:Hearing Loss / Q000097:blood / Q000139:chemically induced* / Q000517:prevention & control; D006801:Humans; D008657:Metabolic Clearance Rate / Q000502:physiology; D051437:Renal Insufficiency / Q000097:blood / Q000139:chemically induced / Q000517:prevention & control; D012307:Risk Factors; D018088:Tuberculosis, Multidrug-Resistant / Q000097:blood / Q000188:drug therapy*; D015837:Vestibular Diseases / Q000097:blood / Q000139:chemically induced* / Q000517:prevention & control
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents